TP53 and breast cancer: Nevertheless, the overexpression of Gal7 had a tumor-promoting behavior in thymic lymphoma and breast cancer [87,88], a paradoxical effect that could be explained by the observation that both NF-κB-binding and TP53 transcription factors can control its expression.